FORMULIERUNGEN AUS BENDAMUSTIN

Patent europeic · EP2827862 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2827862
Numer da la dumonda
EP13764989
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
15-03-2013
Publitgà
28-01-2015
Concedì
27-12-2023
La protecziun finescha il pli tard
14-03-2033
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
A61K 31/4184 (2006.01)
A61K 47/10 (2017.01)
A61K 47/20 (2006.01)
A61K 9/00 (2006.01)
Prioritad
US 201261613173 P 20.03.2012
US 201261669889 P 10.07.2012
Dumonda PCT
PCT/US2013/032289 15.03.2013
Publicaziun PCT
WO2013/142358 26.09.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 06-11-2024

    Midada

    Published in Swissreg on 06.11.2024

  4. 02-04-2024

    Midada

    Published in Swissreg on 02.04.2024

  5. 28-12-2023

    Represchentant inscrit

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 28.12.2023

  6. 27-12-2023

    Concedì

    Published in Swissreg on 27.12.2023

Partidas

Possessur

Eagle Pharmaceuticals, Inc.

50 Tice Boulevard Suite 315, Woodcliff Lake, NJ 07677, US

Represchentant

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventur

SUNDARAM, Srikanth

Somerset, New Jersey 08873, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.